Adalimumab: Another Treatment Option for Moderate-to-Severe UC.
Clinical Professor of Medicine The Inflammatory Bowel Disease Center The Henry D. Janowitz Division of Gastroenterology The Icahn School of Medicine at Mount Sinai New York, New York.
Asher A
AA
Kornbluth